|
1
|
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu
Y, Gong Z, Zhang S, Zhou J, Cao K, et al: Role of tumor
microenvironment in tumorigenesis. J Cancer. 8:761–773. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi
Y, Hu G and Sun Y: New horizons in tumor microenvironment biology:
Challenges and opportunities. BMC Med. 13:452015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hwang YS, Park KK and Chung WY: Stromal
transforming growth factor-beta 1 is crucial for reinforcing the
invasive potential of low invasive cancer. Arch Oral Biol.
59:687–694. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan Y, Jiang YC, Sun CK and Chen QM: Role
of the tumor microenvironment in tumor progression and the clinical
applications (review). Oncol Rep. 35:2499–2515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zi F, He J, He D, Li Y, Yang L and Cai Z:
Fibroblast activation protein α in tumor microenvironment: Recent
progression and implications (review). Mol Med Rep. 11:3203–3211.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raman D, Baugher PJ, Thu YM and Richmond
A: Role of chemokines in tumor growth. Cancer Lett. 256:137–165.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hassona Y, Cirillo N, Heesom K, Parkinson
EK and Prime SS: Senescent cancer-associated fibroblasts secrete
active MMP-2 that promotes keratinocyte dis-cohesion and invasion.
Br J Cancer. 111:1230–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Cho IH, Park JH, Lee MK and Hwang
YS: Fascin is involved in cancer cell invasion and is regulated by
stromal factors. Oncol Rep. 41:465–474. 2019.PubMed/NCBI
|
|
9
|
Hwang YS, Lee J, Zhang X and Lindholm PF:
Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα
signaling and promotes prostate cancer invasion and progression by
enhancing functional invadopodia formation. Tumour Biol.
37:6775–6785. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hoshino D, Branch KM and Weaver AM:
Signaling inputs to invadopodia and podosomes. J Cell Sci.
126:2979–2989. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee D, Yu EJ, Ham IH and Hur H:
Clinicopathological implication of insulin-like growth factor-II
mRNA-binding protein 3 (IMP3) expression in gastric cancer.
Anticancer Res. 37:135–142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murphy DA and Courtneidge SA: The ‘ins’
and ‘outs’ of podosomes and invadopodia: Characteristics, formation
and function. Nat Rev Mol Cell Biol. 12:413–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klemke RL: Trespassing cancer cells:
‘Fingerprinting’ invasive protrusions reveals metastatic culprits.
Curr Opin Cell Biol. 24:662–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tulotta C and Ottewell P: The role of
IL-1B in breast cancer bone metastasis. Endocr Relat Cancer.
25:R421–R434. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Voronov E, Shouval DS, Krelin Y, Cagnano
E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is
required for tumor invasiveness and angiogenesis. Proc Natl Acad
Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang YS, Xianglan Z, Park KK and Chung
WY: Functional invadopodia formation through stabilization of the
PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN
expression. Carcinogenesis. 33:2135–2146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goicoechea SM, García-Mata R, Staub J,
Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ,
Kim HJ and Otey CA: Palladin promotes invasion of pancreatic cancer
cells by enhancing invadopodia formation in cancer-associated
fibroblasts. Oncogene. 33:1265–1273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Veirman K, Rao L, De Bruyne E, Menu E,
Van Valckenborgh E, Van Riet I, Frassanito MA, Di Marzo L, Vacca A
and Vanderkerken K: Cancer associated fibroblasts and tumor growth:
Focus on multiple myeloma. Cancers (Basel). 6:1363–1381. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang FT, Sun W, Zhang JT and Fan YZ:
Cancer-associated fibroblast regulation of tumor neo-angiogenesis
as a therapeutic target in cancer. Oncol Lett. 17:3055–3065.
2019.PubMed/NCBI
|
|
21
|
Tanasubsinn P, Aung WPP, Pata S, Laopajon
W, Makeudom A, Sastraruji T, Kasinrerk W and Krisanaprakornkit S:
Overexpression of ADAM9 in oral squamous cell carcinoma. Oncol
Lett. 15:495–502. 2018.PubMed/NCBI
|
|
22
|
Sung SY, Kubo H, Shigemura K, Arnold RS,
Logani S, Wang R, Konaka H, Nakagawa M, Mousses S, Amin M, et al:
Oxidative stress induces ADAM9 protein expression in human prostate
cancer cells. Cancer Res. 66:9519–9526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yousef GM, Scorilas A and Diamandis EP:
Genomic organization, mapping, tissue expression and hormonal
regulation of trypsin-like serine protease (TLSP PRSS20), a new
member of the human kallikrein gene family. Genomics. 63:88–96.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stavropoulou P, Gregorakis AK, Plebani M
and Scorilas A: Expression analysis and prognostic significance of
human kallikrein 11 in prostate cancer. Clin Chim Acta.
357:190–195. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sano A, Sangai T, Maeda H, Nakamura M,
Hasebe T and Ochiai A: Kallikrein 11 expressed in human breast
cancer cells releases insulin-like growth factor through
degradation of IGFBP-3. Int J Oncol. 30:1493–1498. 2007.PubMed/NCBI
|
|
26
|
Diamandis EP, Okui A, Mitsui S, Luo LY,
Soosaipillai A, Grass L, Nakamura T, Howarth DJ and Yamaguchi N:
Human kallikrein 11: A new biomarker of prostate and ovarian
carcinoma. Cancer Res. 62:295–300. 2002.PubMed/NCBI
|
|
27
|
Kohga K, Tatsumi T, Tsunematsu H, Aono S,
Shimizu S, Kodama T, Hikita H, Yamamoto M, Oze T, Aketa H, et al:
Interleukin-1β enhances the production of soluble MICA in human
hepatocellular carcinoma. Cancer Immunol Immunother. 61:1425–1432.
2012. View Article : Google Scholar : PubMed/NCBI
|
